DIPROSONE Side Effects

7016438-2 | Asthenia, Malaise, Tachycardia
on Sep 16, 2010 Male patient from FRANCE , 63 years of age, was diagnosed with erysipelas and was treated with Diprosone (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, malaise, tachycardia. Diprosone dosage: 1 Df; Bid; Top. During the same period patient was treated with AMOXICILLIN SODIUM (AMOXICILLIN SODIUM) (1 Gm; Bid; Po) (View Amoxicillin Sodium (amoxicillin Sodium) Review and Amoxicillin Sodium (amoxicillin Sodium) Label ), CETIRIZINE DIHCL (CETIRIZINE HYDROCHLORIDE) (1 Df; Qd; Po) (View Cetirizine Dihcl (cetirizine Hydrochloride) Review and Cetirizine Dihcl (cetirizine Hydrochloride) Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), ATACAND (View Atacand Review and Atacand Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), MOPRAL (View Mopral Review and Mopral Label ).

6818975-X | Eczema, Pruritus
Patient was taking Diprosone (View Usage). Patient had the following side effects: eczema (What is eczema?), pruritus on Jun 28, 2010 from FRANCE Additional patient health information: Male patient , 71 years of age, . Diprosone dosage: Top. During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), CACIT D3 (View Cacit D3 Review and Cacit D3 Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.

6104034-0 | Atrial Fibrillation, C-reactive Protein Increased, Dermatitis, Disorientation, Epilepsy, Headache, Hyperthyroidism, Skin Lesion, Somnolence
Adverse event was reported on Feb 19, 2009 by a Female patient taking Diprosone (View Usage) (Dosage: 1 Df;unk;im) was diagnosed with asthma (What is asthma?) and. Location: GERMANY , 71 years of age, weighting 112.4 lb, After Diprosone was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), c-reactive protein increased, dermatitis, disorientation, epilepsy (What is epilepsy?), headache (What is headache?), hyperthyroidism, skin lesion, somnolence. During the same period patient was treated with BERODUAL (View Berodual Review and Berodual Label ), MARCUMAR (View Marcumar Review and Marcumar Label ). Patient was hospitalized.

5378501-1 | Cerebral Thrombosis
on Jun 21, 2007 Male patient from DENMARK , 69 years of age, weighting 143.3 lb, was diagnosed with irritability, nasal mucosal disorder and was treated with Diprosone (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral thrombosis. Diprosone dosage: Im. During the same period patient was treated with AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ). Patient was hospitalized and became disabled.


5252905-X | Antinuclear Antibody Positive, Burning Sensation, C-reactive Protein Increased, Erythema, Intertrigo, Neutrophil Count Increased, Oedema, Pustular Psoriasis, Rash Pustular
on Feb 26, 2007 Female patient from FRANCE , 46 years of age, weighting 260.1 lb, was diagnosed with migraine (What is migraine?), contraception, intertrigo and was treated with Diprosone (View Usage). Patient had the following side effects: antinuclear antibody positive, burning sensation, c-reactive protein increased, erythema, intertrigo, neutrophil count increased, oedema, pustular psoriasis, rash pustular. Diprosone dosage: 1 Df, Qd. During the same period patient was treated with NOCERTONE (60 Mg, Bid) (View Nocertone Review and Nocertone Label ), PROPOFAN ^AVENTIS^ (View Propofan ^aventis^ Review and Propofan ^aventis^ Label ), CERAZETTE (0.075 Mg, Qd) (View Cerazette Review and Cerazette Label ), ECONAZOLE NITRATE (1 Df, Qd) (View Econazole Nitrate Review and Econazole Nitrate Label ), AMYCOR (View Amycor Review and Amycor Label ), LAMISIL (250 Mg, Qd) (View Lamisil Review and Lamisil Label ). Patient was hospitalized.

5245925-2 | Antinuclear Antibody Positive, Burning Sensation, Intertrigo, Monocyte Count Increased, Neutrophil Count Increased, Oedema Peripheral, Pustular Psoriasis, White Blood Cell Count Increased
Patient was taking Diprosone (View Usage). After Diprosone was administered, patient had the following side effects: antinuclear antibody positive, burning sensation, intertrigo, monocyte count increased, neutrophil count increased, oedema peripheral, pustular psoriasis, white blood cell count increased on Feb 14, 2007 from FRANCE Additional patient health information: Female patient , 46 years of age, weighting 260.1 lb, was diagnosed with migraine (What is migraine?), intertrigo, contraception and. Diprosone dosage: Qd; Top. During the same period patient was treated with NOCERTONE (OXETORONE FUMARATE) (60 Mg;bid;po) (View Nocertone (oxetorone Fumarate) Review and Nocertone (oxetorone Fumarate) Label ), PROPOFAN (PROPOFAN /01607901/) (27 Mg;prn;po) (View Propofan (propofan /01607901/) Review and Propofan (propofan /01607901/) Label ), LAMISIL (250 Mg;qd;po) (View Lamisil Review and Lamisil Label ), CERAZETTE (DESOGESTREL) (1 Df;qd;po) (View Cerazette (desogestrel) Review and Cerazette (desogestrel) Label ), ECONAZOLE (ECONAZOLE) (Top) (View Econazole (econazole) Review and Econazole (econazole) Label ). Patient was hospitalized.

5243218-0 | Intertrigo, Pustular Psoriasis
Adverse event was reported on Feb 07, 2007 by a Female patient taking Diprosone (View Usage) (Dosage: Qd;top) was diagnosed with migraine (What is migraine?), intertrigo, contraception and. Location: FRANCE , 46 years of age, weighting 260.1 lb, Patient experienced the following unwanted or unexpected effects: intertrigo, pustular psoriasis. During the same period patient was treated with NOCERTONE (OXETORONE FUMARATE) (60 Mg;bid;po) (View Nocertone (oxetorone Fumarate) Review and Nocertone (oxetorone Fumarate) Label ), PROPOFAN (PROPOFAN /01607901/) (27 Mg;prn;po) (View Propofan (propofan /01607901/) Review and Propofan (propofan /01607901/) Label ), LAMISIL (250 Mg;qd;po) (View Lamisil Review and Lamisil Label ), CERAZETTE (DESOGESTREL) (1 Df;qd;po) (View Cerazette (desogestrel) Review and Cerazette (desogestrel) Label ), ECONAZOLE (ECONAZOLE) (Top) (View Econazole (econazole) Review and Econazole (econazole) Label ). Patient was hospitalized.

5223596-9 | Intertrigo, Pustular Psoriasis
on Jan 12, 2007 Female patient from FRANCE , 46 years of age, weighting 118.0 lb, was diagnosed with migraine (What is migraine?), contraception and was treated with Diprosone (View Usage). Patient had the following side effects: intertrigo, pustular psoriasis. Diprosone dosage: . During the same period patient was treated with NOCERTONE (OXETORONE FUMARATE) (60 Mg; Bid; Po) (View Nocertone (oxetorone Fumarate) Review and Nocertone (oxetorone Fumarate) Label ), PROPOFAN (PROPOFAN 01607901/) (27 Mg; Prn; Po) (View Propofan (propofan 01607901/) Review and Propofan (propofan 01607901/) Label ), LAMISIL (250 Mg; Qd; Po) (View Lamisil Review and Lamisil Label ), CERAZETTE (DESOGESTREL) (1 Df; Qd; Po) (View Cerazette (desogestrel) Review and Cerazette (desogestrel) Label ), ECONAZOLE (ECONAZOLE) (Top) (View Econazole (econazole) Review and Econazole (econazole) Label ). Patient was hospitalized.

5020298-9 | Anaphylactic Shock, Autoimmune Disorder, Condition Aggravated, Loss Of Consciousness, Road Traffic Accident
on May 24, 2006 Female patient from AUSTRALIA , 61 years of age, was diagnosed with papilloma and was treated with Diprosone (View Usage). After Diprosone was administered, patient had the following side effects: anaphylactic shock, autoimmune disorder, condition aggravated, loss of consciousness, road traffic accident. Diprosone dosage: Bid Top-derm. During the same period patient was treated with THYROXIN (View Thyroxin Review and Thyroxin Label ).

5016967-7 | Hypersensitivity, Loss Of Consciousness, Road Traffic Accident, Somnolence
Patient was taking Diprosone (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity, loss of consciousness, road traffic accident, somnolence on May 17, 2006 from AUSTRALIA Additional patient health information: Female patient , 61 years of age, was diagnosed with pseudopapilloedema and. Diprosone dosage: Bid Top-derm. During the same period patient was treated with THYROXIN (View Thyroxin Review and Thyroxin Label ).

4956300-X | Acne, Dermatitis Exfoliative, Parakeratosis, Skin Exfoliation, Toxic Skin Eruption, Vasculitis
Adverse event was reported on Mar 14, 2006 by a Male patient taking Diprosone (View Usage) (Dosage: Top-derm) was diagnosed with vasculitis (What is vasculitis?), asthenia, rash (What is rash?) and. Location: FRANCE , 77 years of age, Patient had the following side effects: acne (What is acne?), dermatitis exfoliative, parakeratosis, skin exfoliation, toxic skin eruption, vasculitis (What is vasculitis?). During the same period patient was treated with GURONSAN EFFERVESCENT TABLETS (Oral) (View Guronsan Effervescent Tablets Review and Guronsan Effervescent Tablets Label ), LOCOID (Top-derm) (View Locoid Review and Locoid Label ), LAMISIL (Top-derm) (View Lamisil Review and Lamisil Label ), SOLUPRED EFFERVESCENT TABLETS (Oral) (View Solupred Effervescent Tablets Review and Solupred Effervescent Tablets Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), EBASTINE (View Ebastine Review and Ebastine Label ). Patient was hospitalized.

4909935-4 | Dermatitis Psoriasiform, Parakeratosis, Skin Exfoliation, Toxic Skin Eruption, Vasculitis
on Jan 27, 2006 Male patient from FRANCE , 77 years of age, was diagnosed with vasculitis (What is vasculitis?), asthenia, rash (What is rash?) and was treated with Diprosone (View Usage). After Diprosone was administered, patient had the following side effects: dermatitis psoriasiform, parakeratosis, skin exfoliation, toxic skin eruption, vasculitis (What is vasculitis?). Diprosone dosage: Top-derm. During the same period patient was treated with GURONSAN EFFERVESCENT TABLETS (Oral) (View Guronsan Effervescent Tablets Review and Guronsan Effervescent Tablets Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), EBASTINE (View Ebastine Review and Ebastine Label ), LOCOID (Top-derm) (View Locoid Review and Locoid Label ), LAMISIL (Top-derm) (View Lamisil Review and Lamisil Label ), SOLUPRED EFFERVESCENT TABLETS (Oral) (View Solupred Effervescent Tablets Review and Solupred Effervescent Tablets Label ), EFFERALGAN (View Efferalgan Review and Efferalgan Label ). Patient was hospitalized.

4843055-2 | Gingival Bleeding, Petechiae, Thrombocytopenic Purpura
on Nov 23, 2005 Female patient from FRANCE , 86 years of age, was treated with Diprosone (View Usage). Patient experienced the following unwanted or unexpected effects: gingival bleeding, petechiae, thrombocytopenic purpura. Diprosone dosage: Top-derm. During the same period patient was treated with ALDACTAZIDE (1 Qd Oral) (View Aldactazide Review and Aldactazide Label ), HYPERIUM (RILMENIDINE) TABLETS (View Hyperium (rilmenidine) Tablets Review and Hyperium (rilmenidine) Tablets Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.

4673429-4 | Clumsiness, Fall, Glaucoma, Telangiectasia, Visual Field Defect
Patient was taking Diprosone (View Usage). Patient had the following side effects: clumsiness, fall (What is fall?), glaucoma (What is glaucoma?), telangiectasia, visual field defect on May 12, 2005 from Additional patient health information: Female patient , 29 years of age, was diagnosed with eczema (What is eczema?) and. Diprosone dosage: 0.05% Topical.

4616083-X | Bullous Impetigo, Dermatitis Bullous, Pneumonia Staphylococcal, Pyrexia, Sepsis, Skin Atrophy, Sleep Disorder, Staphylococcal Impetigo, Staphylococcal Infection
Adverse event was reported on Mar 11, 2005 by a Female patient taking Diprosone (View Usage) (Dosage: Top-derm) was diagnosed with sleep disorder (What is sleep disorder?), ear pruritus and. Location: , 91 years of age, After Diprosone was administered, patient had the following side effects: bullous impetigo, dermatitis bullous, pneumonia staphylococcal, pyrexia, sepsis (What is sepsis?), skin atrophy, sleep disorder (What is sleep disorder?), staphylococcal impetigo, staphylococcal infection (What is staphylococcal infection?). During the same period patient was treated with SOLUPRED (Oral) (View Solupred Review and Solupred Label ), TANAKAN (Tid Oral) (View Tanakan Review and Tanakan Label ), NOCTRAN 10 TABLETS (10 Mg Qd Oral) (View Noctran 10 Tablets Review and Noctran 10 Tablets Label ), ORBENIN CAP (500 Mg Bid Oral) (View Orbenin Cap Review and Orbenin Cap Label ), JECOPEPTOL ORAL POWDER (Oral) (View Jecopeptol Oral Powder Review and Jecopeptol Oral Powder Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), BEPANTHEN (View Bepanthen Review and Bepanthen Label ), GLYCEROL 2.6% (View Glycerol 2.6% Review and Glycerol 2.6% Label ). Patient was hospitalized.

4607545-X | Pruritus, Toxic Skin Eruption
on Mar 03, 2005 Female patient from , 73 years of age, was treated with Diprosone (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, toxic skin eruption. Diprosone dosage: Top-derm. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ALKERAN (View Alkeran Review and Alkeran Label ), LYTOS (View Lytos Review and Lytos Label ). Patient was hospitalized.

4596909-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Disease Progression, Enterococcal Infection, Escherichia Infection, Inflammation, Lymphocyte Count Increased, Neutrophil Count Decreased
on Feb 15, 2005 Female patient from , 30 years of age, was diagnosed with exanthem and was treated with Diprosone (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, disease progression, enterococcal infection, escherichia infection, inflammation, lymphocyte count increased, neutrophil count decreased. Diprosone dosage: Top-derm. During the same period patient was treated with DERMATOP OINTMENT (View Dermatop Ointment Review and Dermatop Ointment Label ), BETALOC (View Betaloc Review and Betaloc Label ). Patient was hospitalized.

4591129-6 | Disease Progression, Pityriasis Lichenoides Et Varioliformis Acuta
Patient was taking Diprosone (View Usage). After Diprosone was administered, patient had the following side effects: disease progression, pityriasis lichenoides et varioliformis acuta on Feb 09, 2005 from Additional patient health information: Female patient , 30 years of age, was diagnosed with exanthem and. Diprosone dosage: Top-derm. During the same period patient was treated with DERMATOP OINTMENT (View Dermatop Ointment Review and Dermatop Ointment Label ), BETALOC (View Betaloc Review and Betaloc Label ). Patient was hospitalized.

4583537-4 | Blood Pressure Systolic Increased, Gingival Bleeding, Thrombocytopenic Purpura
Adverse event was reported on Feb 02, 2005 by a Female patient taking Diprosone (View Usage) (Dosage: Top-derm) . Location: , 86 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure systolic increased, gingival bleeding, thrombocytopenic purpura. During the same period patient was treated with ALDACTAZINE TABLETS (1 Qd Oral) (View Aldactazine Tablets Review and Aldactazine Tablets Label ), HYPERIUM (RILMENIDINE) TABLETS (View Hyperium (rilmenidine) Tablets Review and Hyperium (rilmenidine) Tablets Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.

4551320-1 | Bullous Impetigo, Dermatitis Bullous, Pneumonia Staphylococcal, Sepsis, Skin Atrophy, Staphylococcal Impetigo
on Dec 31, 2004 Female patient from , 91 years of age, was diagnosed with sleep disorder (What is sleep disorder?), pruritus and was treated with Diprosone (View Usage). Patient had the following side effects: bullous impetigo, dermatitis bullous, pneumonia staphylococcal, sepsis (What is sepsis?), skin atrophy, staphylococcal impetigo. Diprosone dosage: Top-derm. During the same period patient was treated with MANNIT 15% (MANNITOL) (View Mannit 15% (mannitol) Review and Mannit 15% (mannitol) Label ), SOLUPRED (Oral) (View Solupred Review and Solupred Label ), TANAKAN (Tid Oral) (View Tanakan Review and Tanakan Label ), NOCTRAN 10 (10 Mg Qd Oral) (View Noctran 10 Review and Noctran 10 Label ), ORBENIN CAP (500 Mg Bid Oral) (View Orbenin Cap Review and Orbenin Cap Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), BEPANTHEN (View Bepanthen Review and Bepanthen Label ), GLYCEROL 2.6% (View Glycerol 2.6% Review and Glycerol 2.6% Label ). Patient was hospitalized.